A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

Full Title

A Phase II Study of BIO 300 to Reduce the Toxicity of Thoracic Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease (BREATHE)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Narek Shaverdian’s office at 631-212-6323.